These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 23723597)
1. Cosmeceuticals for Hyperpigmentation: What is Available? Sarkar R; Arora P; Garg KV J Cutan Aesthet Surg; 2013 Jan; 6(1):4-11. PubMed ID: 23723597 [TBL] [Abstract][Full Text] [Related]
2. Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion. Sofen B; Prado G; Emer J Skin Therapy Lett; 2016 Jan; 21(1):1-7. PubMed ID: 27224897 [TBL] [Abstract][Full Text] [Related]
3. Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation. Ko D; Wang RF; Ozog D; Lim HW; Mohammad TF J Am Acad Dermatol; 2023 Feb; 88(2):291-320. PubMed ID: 35158001 [TBL] [Abstract][Full Text] [Related]
10. The top 10 cosmeceuticals for facial hyperpigmentation. Searle T; Al-Niaimi F; Ali FR Dermatol Ther; 2020 Nov; 33(6):e14095. PubMed ID: 32720446 [TBL] [Abstract][Full Text] [Related]
11. The role of systemic treatments for skin lightening. Juhasz MLW; Levin MK J Cosmet Dermatol; 2018 Dec; 17(6):1144-1157. PubMed ID: 30133125 [TBL] [Abstract][Full Text] [Related]
12. The Use of Botanical Extracts in East Asia for Treatment of Hyperpigmentation: An Evidenced-Based Review. Hu S; Wolfe S; Laughter MR; Sadeghpour M J Drugs Dermatol; 2020 Jul; 19(7):758-763. PubMed ID: 32726104 [TBL] [Abstract][Full Text] [Related]
13. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation. Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541 [TBL] [Abstract][Full Text] [Related]
16. Lasers for treatment of melasma and post-inflammatory hyperpigmentation. Arora P; Sarkar R; Garg VK; Arya L J Cutan Aesthet Surg; 2012 Apr; 5(2):93-103. PubMed ID: 23060704 [TBL] [Abstract][Full Text] [Related]
17. A case report on the use of topical cysteamine 5% cream in the management of refractory postinflammatory hyperpigmentation (PIH) resistant to triple combination cream (hydroquinone, topical corticosteroids, and retinoids). Mathe N; Balogun M; Yoo J J Cosmet Dermatol; 2021 Jan; 20(1):204-206. PubMed ID: 32997864 [TBL] [Abstract][Full Text] [Related]
18. Marine-Derived Compounds with Potential Use as Cosmeceuticals and Nutricosmetics. Alves A; Sousa E; Kijjoa A; Pinto M Molecules; 2020 May; 25(11):. PubMed ID: 32486036 [TBL] [Abstract][Full Text] [Related]
19. Treatment of melasma with topical agents, peels and lasers: an evidence-based review. Rivas S; Pandya AG Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551 [TBL] [Abstract][Full Text] [Related]
20. Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies. Breathnach AS Cutis; 1996 Jan; 57(1 Suppl):36-45. PubMed ID: 8654129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]